Chemoinformaics analysis of DOCECA-2E,4E,8Z,10E/Z-TETRAENOIC-ACID-ISOBUTYLAMIDES
Molecular Weight | 338.576 | nRot | 19 |
Heavy Atom Molecular Weight | 296.24 | nRig | 2 |
Exact Molecular Weight | 338.318 | nRing | 0 |
Solubility: LogS | -6.266 | nHRing | 0 |
Solubility: LogP | 8.869 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 66.3493 |
nHD | 1 | BPOL | 43.0027 |
QED | 0.194 |
Synth | 2.191 |
Natural Product Likeliness | 0.876 |
NR-PPAR-gamma | 0.965 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.009 |
CACO-2 | -5.011 |
MDCK | 0.0000177 |
BBB | 0.03 |
PPB | 0.992524 |
VDSS | 0.995 |
FU | 0.00974786 |
CYP1A2-inh | 0.218 |
CYP1A2-sub | 0.158 |
CYP2c19-inh | 0.279 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.109 |
CYP2c9-sub | 0.992 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.035 |
CYP3a4-inh | 0.088 |
CYP3a4-sub | 0.01 |
CL | 2.759 |
T12 | 0.271 |
hERG | 0.072 |
Ames | 0.004 |
ROA | 0.009 |
SkinSen | 0.959 |
Carcinogencity | 0.072 |
EI | 0.968 |
Respiratory | 0.8 |
NR-Aromatase | 0.325 |
Antiviral | No |
Prediction | 0.575712 |